Synergistic effect of platelet-activating factor and tumor necrosis factor-α on corneal myofibroblast apoptosis

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 3, 2006, Pages 883-891

  He, Jiucheng ^a   Bazan, Haydee E P ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,6 TRIMETHYL 1,4 DIHYDRO 3,5 PYRIDINEDICARBOXYLIC ACID 2 (3,4 DICHLOROPHENOXY)ETHYL BIS(MORPHOLINOMETHYL)METHYL ESTER; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; DIHYDROPYRIDINE DERIVATIVE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOPLASM; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; FLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; MYOFIBROBLAST; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CORNEA; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; SWINE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL MEMBRANE; CELLS, CULTURED; CORNEA; CYTOPLASM; DIHYDROPYRIDINES; DRUG COMBINATIONS; DRUG SYNERGISM; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IN SITU NICK-END LABELING; MICROSCOPY, FLUORESCENCE; NUCLEAR ENVELOPE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645384039     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0581     Document Type: Article

References (47)

1. Birk DE, Fitch JM, Linsenmayer TF. Organization of collagen type I and V in the embryonic chicken cornea. Invest Ophthalmol Vis Sci. 1986;27:1470-1477.
2. Wessel H, Anderson S, Fite D, Halvas E, Hempel J, Sundar Raj N. Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices. Invest Ophthalmol Vis Sci. 1997;38:2408-2422.
3. Li W, Vergnes J-P, Cornuet PK, Hassell JR. cDNA clone to chick cornea chondroitin/dermatan sulfate proteoglycan reveals identity to decorin. Arch Biochem Biophys. 1992;296:190-197.
4. Hassell JR, Cintron C, Kublin C, Newsome DA. Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys. 1983;222:362-369.
5. Funderburgh JL, Funderburgh ML, Mann MM, Prakash S, Conrad GW. Synthesis of corneal keratan sulfate proteoglycans by bovine keratocytes in vitro. J Biol Chem. 1996;271:31431-31436.
6. Cintron C, Hassinger LC, Kublin CL, Cannon DJ. Biochemical and ultrastructural changes in collagen during corneal wound healing. J Ultrastruct Res. 1978;65:13-22.
7. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res. 1999;18:529-551.
8. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999;18:311-356.
9. Cintron C, Covington HI, Kublin CL. Morphologic analysis of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci. 1990;31:1789-1798.
10. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am J Pathol. 1994;145:114-125.
11. Badid C, Mounier N, Costa AM, Desmouliere A. Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies. Histol Histopathol. 2000;15:269-280.
12. Garana RM, Petroll WM, Chen WT, et al. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci. 1992;33:3271-3282.
13. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci. 1995;36:809-819.
14. Esquenazi S, He J, Bazan HE, Bazan NG. Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist. J Cataract Refract Surg. 2004;30:884-891.
15. Wilson SE. Analysis of the keratocyte apoptosis, keratocyte proliferation, and myofibroblast transformation responses after photorefractive keratectomy and laser in situ keratomileusis. Trans Am Ophthalmol Soc. 2002;100:411-433.
16. Desmouliere A, Redard M, Darby I, Gabbani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995;146:56-66.
17. Bazan HEP, Reddy ST, Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp Eye Res. 1991;52:481-491.
18. Chandraekher G, Ma X, Bazan HEP. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci. 2002;43:1422-1428.
19. He J, Bazan NG, Bazan HEP. Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor (PAF) receptor antagonist. Arch Ophthalmol. 2006;124:70-78.
20. Bazan HEP, Ottino P. The role of platelet-activating factor in the corneal response to injury. Prog Retin Eye Res. 2002;21:449-464.
21. Ma X, Bazan HEP. Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cells through cytochrome c-caspase activation. Curr Eye Res. 2001;23:326-335.
22. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines, and disease. Annu Rev Cell Biol. 1993;9:317-343.
23. Sotozono C, He J, Tei M, Honma Y, Kinoshita S. Effect of metallo-proteinase inhibitor on corneal cytokine expression after alkali injury. Invest Ophthalmol Vis Sci. 1999;40:2430-2434.
24. He J, Ichimura H, Iida T, et al. Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J Interferon Cytokine Res. 1999;19:609-615.
25. Mohan RR, Mohan RR, Kim W-J, Wilson SE. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB. Invest Ophthalmol Vis Sci. 2000;41:1327-1336.
26. Bazan NG, Sunkel C, Marcheselli VL, Builla-GL. LSU Health Sciences Center, assignee. 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid Esters as Neuroprotective Drugs. US patent 6566,359B1. 2003.
27. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA. 1996;93:4219-4223.
28. Ottino P, He J, Axelrad TW, Bazan HEP. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. Invest Ophthalmol Vis Sci. 2005;46:487-496.
29. Ma X, Bazan HEP. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2000;41:1969-1702.
30. Berryhill BL, Kader R, Kane B, Birk DE, Feng J, Hassell JR. Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Invest Ophthalmol Vis Sci. 2002;43:3416-3421.
31. Maltseva O, Folger P, Zekaria D, Petridou S, Masur SK. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci. 2001;42:2490-2495.
32. Funderburgh JL, Funderburgh ML, Mann M, Corpuz L, Roth MR. Proteoglycan expression during transforming growth factor beta-induced keratocyte- myofibroblast transdifferentiation. J Biol Chem. 2001;276:44173-44178.
33. Bhattacharya M, Pery K, Ribeiro da Silva A, et al. Localization of functional prostaglandin E2 receptors EP3 and EP4 in nuclear envelope. J Biol Chem. 1999;274:15719-15724.
34. Ventura CP, Wolchock J, Hull ML, Howell SM. Nuclear opioid receptors activate peptide gene transcription in isolated myocardial nuclei. J Biol Chem. 1998;273:13383-13386.
35. Marrache AM, Gobiel F, Bernier SG, et al. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol. 2002;169:6474-6481.
36. Chase PB, Halonen M, Regan JW. Cloning of a human platelet activating factor receptor gene: evidence for an intron in the 5 -untranslated region. Am J Respir Cell Mol Biol. 1993;8:240-244.
37. Zimmerman RJ, Chan A, Leadon A. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res. 1989;49:1644-1648.
38. Myers AK, Robey JW, Price RM. Relationship between tumor necrosis factor, eicosanoids and platelet-activating factor as mediator of endotoxin-induced shock in mice. Br J Pharmacol. 1990;99:499-502.
39. Gomez-Chiarri M, Ortiz A, Lerma JL, et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest. 1994;70:449-459.
40. Nottet HSLM, Jett M, Flanagan CR, et al. A regulatory role for astrocytes in HIV-1 encephalitis. J Immunol. 1995;154:3567-3581.
41. Sun XM, Huseh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest. 1988;81:1328-1331.
42. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med. 1987;166:1390-1404.
43. Dagenais P, Thivierge M, Parent JL, Stankova J, Rola-Pleszczynski M. Augmented expression of platelet-activating factor receptor gene by TNF-alpha through transcriptional activation in human monocytes. J Leukoc Biol. 1997;61:106-112.
44. Dubois C, Bissonntte E, Rola-Pleszczynski M. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. J Immunol. 1989;143:964-970.
45. Ruis NM, Rose JK, Valone FH. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids. 1991;26:1060-1064.
46. Hume E, Sack R, Stapleton F, Willcox M. Induction of cytokines from polymorphonuclear leukocytes and epithelial cells by ocular isolates of Serratia marcescens. Ocul Immunol Inflamm. 2004;12:287-295.
47. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293-4301.